Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-25-220847

Chief Executive Officer sold 25,797 shares at $9.77 ($252,037)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Barrow Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-25 Sale : show line 1 in the form 10b5-1 −25,797 $9.77 $252,037 804,268 D
Open-market sales · 25,797 sh · avg $9.77 · $252,037
Loading xslF345X05/ownership.xml…